1. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission 
Se-Hoon Lee, Mark H. Lee, Je-Hwan Lee, Yoo Hong Min, Kyoo-Hyung Lee, June-Won Cheong, Jeeyun Lee, Keon Woo Park, Jung Hun Kang, Kihyun Kim, Won Seog Kim, Chul Won Jung, Seong-Jun Choi, Jung-Hee Lee, Keunchil Park 
Biology of Blood and Marrow Transplantation 
Volume 11, Issue 2, Pages (February 2005)
DOI: /j.bbmt
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Overall survival according to CD34+ cell dose.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2 Leukemia-free survival according to CD34+ cell dose.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Transplant-related mortality according to CD34+ cell dose. BMT indicates bone marrow transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Relapse incidence according to CD34+ cell dose. BMT indicates bone marrow transplantation.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions